Skip to content

Bachem CIO Predicts AI-Driven Drug Breakthroughs in Next Decade

AI could revolutionize healthcare with new treatments. But data privacy and ethics must be prioritized, says Bachem's CIO in a new podcast episode.

In this image, we can see an advertisement contains robots and some text.
In this image, we can see an advertisement contains robots and some text.

Bachem CIO Predicts AI-Driven Drug Breakthroughs in Next Decade

Achim Plueckbaum, CIO of Bachem, has shared his vision of AI's transformative impact on medicine and pharmacology in a podcast episode of Mike & Amit Talk Tech. The episode, available on Apple and Spotify, explores the future of medicine with Plueckbaum, who is also a contributor to the podcast hosts' latest book, GAIN.

Plueckbaum predicts significant advancements in AI-driven drug innovations within the next decade. He foresees the discovery of entirely new treatments, highlighting the potential of AI in revolutionising healthcare. The CIO of Bachem believes that AI will not only transform medicine and pharmacology but also patient care.

In the podcast, Plueckbaum emphasises the importance of data privacy and ethical considerations in AI development for healthcare. He underscores the need for responsible innovation to ensure the benefits of AI are realised without compromising patient data or trust.

The podcast episode, hosted by Michael R. Wade, TONOMUS Professor of Strategy and Digital, and Amit M. Joshi, Professor of AI, Analytics, and Marketing Strategy, offers insights into the future of medicine and the role of AI in shaping it. Plueckbaum's predictions serve as a reminder of the potential and the responsibilities that come with AI-driven innovation in healthcare.

Read also:

Latest